Mesa Laboratories, Inc.
MLAB
$126.18
$3.853.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26,412.55% | -34,160.95% | -13,860.80% | -27,438.28% | 164.71% |
| Total Depreciation and Amortization | -30.67% | -18.98% | -12.76% | -4.71% | -1.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,641.36% | 2,027.62% | 1,816.82% | 2,264.54% | -36.99% |
| Change in Net Operating Assets | 1,103.30% | 146.19% | 187.30% | 134.91% | 97.54% |
| Cash from Operations | 7.44% | 0.43% | 9.56% | 57.71% | 76.73% |
| Capital Expenditure | -31.69% | -21.15% | 30.53% | 43.51% | 28.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.21% | -1,490.69% | -1,490.69% | -1,490.69% | -1,510.10% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.30% | -873.53% | -758.86% | -756.39% | -794.68% |
| Total Debt Issued | 3.47% | -- | -- | -- | -- |
| Total Debt Repaid | -290.62% | -302.31% | -152.83% | 6.94% | 31.71% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -100.00% | -61.22% |
| Repurchase of Common Stock | 80.00% | 99.42% | 99.78% | 99.78% | 98.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.67% | -0.67% | -0.85% | -1.20% | -1.33% |
| Other Financing Activities | -189.66% | -510.89% | -139.09% | -- | -21,500.00% |
| Cash from Financing | -199.69% | 206.50% | 180.23% | 198.52% | 206.14% |
| Foreign Exchange rate Adjustments | 107.92% | 742.61% | 113.33% | 77.52% | 87.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.69% | -448.15% | 65.67% | 71.43% | 108.29% |
